TVRD
Tvardi Therapeutics
TVRD
TVRD
97 hedge funds and large institutions have $21.7M invested in Tvardi Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 33
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
Holders
97
Holding in Top 10
–
Calls
$46K
Puts
$4K
Top Buyers
| 1 | +$1.41M | |
| 2 | +$578K | |
| 3 | +$466K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$390K |
| 5 |
Millennium Management
New York
|
+$177K |
Top Sellers
| 1 | -$746K | |
| 2 | -$727K | |
| 3 | -$518K | |
| 4 |
Morgan Stanley
New York
|
-$437K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$163K |